Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
- PMID: 34937050
- PMCID: PMC8828469
- DOI: 10.1038/s41586-021-04342-0
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
Abstract
Emerging variants of concern (VOCs) are driving the COVID-19 pandemic1,2. Experimental assessments of replication and transmission of major VOCs and progenitors are needed to understand the mechanisms of replication and transmission of VOCs3. Here we show that the spike protein (S) from Alpha (also known as B.1.1.7) and Beta (B.1.351) VOCs had a greater affinity towards the human angiotensin-converting enzyme 2 (ACE2) receptor than that of the progenitor variant S(D614G) in vitro. Progenitor variant virus expressing S(D614G) (wt-S614G) and the Alpha variant showed similar replication kinetics in human nasal airway epithelial cultures, whereas the Beta variant was outcompeted by both. In vivo, competition experiments showed a clear fitness advantage of Alpha over wt-S614G in ferrets and two mouse models-the substitutions in S were major drivers of the fitness advantage. In hamsters, which support high viral replication levels, Alpha and wt-S614G showed similar fitness. By contrast, Beta was outcompeted by Alpha and wt-S614G in hamsters and in mice expressing human ACE2. Our study highlights the importance of using multiple models to characterize fitness of VOCs and demonstrates that Alpha is adapted for replication in the upper respiratory tract and shows enhanced transmission in vivo in restrictive models, whereas Beta does not overcome Alpha or wt-S614G in naive animals.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
SARS-CoV-2 spike D614G change enhances replication and transmission.Nature. 2021 Apr;592(7852):122-127. doi: 10.1038/s41586-021-03361-1. Epub 2021 Feb 26. Nature. 2021. PMID: 33636719
-
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters.PLoS Pathog. 2022 Feb 10;18(2):e1009914. doi: 10.1371/journal.ppat.1009914. eCollection 2022 Feb. PLoS Pathog. 2022. PMID: 35143587 Free PMC article.
-
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.Science. 2020 Dec 18;370(6523):1464-1468. doi: 10.1126/science.abe8499. Epub 2020 Nov 12. Science. 2020. PMID: 33184236 Free PMC article.
-
Making sense of spike D614G in SARS-CoV-2 transmission.Sci China Life Sci. 2021 Jul;64(7):1062-1067. doi: 10.1007/s11427-020-1893-9. Epub 2021 Feb 4. Sci China Life Sci. 2021. PMID: 33587268 Free PMC article. Review.
-
Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.J Biol Chem. 2021 Jan-Jun;296:100135. doi: 10.1074/jbc.REV120.015980. Epub 2020 Dec 6. J Biol Chem. 2021. PMID: 33268377 Free PMC article. Review.
Cited by
-
Antibody-mediated immunity to SARS-CoV-2 spike.Adv Immunol. 2022;154:1-69. doi: 10.1016/bs.ai.2022.07.001. Epub 2022 Aug 22. Adv Immunol. 2022. PMID: 36038194 Free PMC article. Review.
-
Influenza Infection in Ferrets with SARS-CoV-2 Infection History.Microbiol Spectr. 2022 Dec 21;10(6):e0138622. doi: 10.1128/spectrum.01386-22. Epub 2022 Oct 27. Microbiol Spectr. 2022. PMID: 36301107 Free PMC article.
-
Population immunity predicts evolutionary trajectories of SARS-CoV-2.Cell. 2023 Nov 9;186(23):5151-5164.e13. doi: 10.1016/j.cell.2023.09.022. Epub 2023 Oct 23. Cell. 2023. PMID: 37875109 Free PMC article.
-
Relative infectivity of the SARS-CoV-2 Omicron variant in human alveolar cells.iScience. 2022 Dec 22;25(12):105571. doi: 10.1016/j.isci.2022.105571. Epub 2022 Nov 13. iScience. 2022. PMID: 36406862 Free PMC article.
-
The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model.Commun Biol. 2022 Mar 10;5(1):225. doi: 10.1038/s42003-022-03171-9. Commun Biol. 2022. PMID: 35273335 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
